Column Capital Advisors, LLC Sarepta Therapeutics, Inc. Transaction History

Column Capital Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$117.53 - $155.99 $83,798 - $111,220	-713 Reduced 57.73%	522 $71,000
Q4 2022 Feb 06, 2023	SELL	$100.86 - $132.13 $28,946 - $37,921	-287 Reduced 18.86%	1,235 $160,000
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $32,782 - $51,630	-433 Reduced 22.15%	1,522 $168,000
Q2 2022 Aug 04, 2022	SELL	$62.69 - $88.44 $56,922 - $80,303	-908 Reduced 31.71%	1,955 $147,000
Q4 2021 Feb 07, 2022	SELL	$77.28 - $99.42 $7,573 - $9,743	-98 Reduced 3.31%	2,863 $258,000
Q3 2021 Nov 10, 2021	SELL	$65.97 - $92.48 $4,683 - $6,566	-71 Reduced 2.34%	2,961 $274,000
Q2 2021 Aug 05, 2021	BUY	$69.38 - $86.75 $97,340 - $121,710	1,403 Added 86.13%	3,032 $236,000
Q1 2021 May 10, 2021	BUY	$72.25 - $168.95 $78,824 - $184,324	1,091 Added 202.79%	1,629 $121,000
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $58,134 - $82,756	-463 Reduced 46.25%	538 $92,000
Q1 2020 May 11, 2020	SELL	$82.38 - $131.64 $2,883 - $4,607	-35 Reduced 3.38%	1,001 $98,000
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $79,285 - $140,460	1,036 New	1,036 $133,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Column Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Column Capital Advisors, LLC with notifications on news.